Pyridoxine-dependent epilepsy in Tunisia is caused by a founder missense mutation of the ALDH7A1 gene

被引:13
作者
Tlili, Abdelaziz [1 ]
Hentati, Nadia Hamida [2 ]
Chaabane, Rim [1 ]
Gargouri, Abdellatif [2 ]
Fakhfakh, Faiza [1 ]
机构
[1] Univ Sfax, Lab Genet Mol Humaine, Fac Med Sfax, Sfax, Tunisia
[2] CHU Hedi Chaker Sfax, Serv Neonatol, Sfax, Tunisia
关键词
Pyridoxine-dependent epilepsy; ALDH7A1; gene; Mutation; Founder effect; c.1364T > C; p.Leu455Pro; TERM-FOLLOW-UP; SEIZURES; ANTIQUITIN; DIAGNOSIS;
D O I
10.1016/j.gene.2013.01.041
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by seizures and therapeutic response to pharmacological dose of pyridoxine. Mutations in the ALDH7A1 gene, encoding alpha-aminoadipic semialdehyde (alpha-AASA) dehydrogenase (antiquitin), have been reported to cause PDE in most patients. In this study molecular analysis of seven PDE Tunisian patients revealed a common missense c.1364T>C mutation in the ALDH7A1 gene. The identification of a cluster of PDE pedigrees carrying the c.1364T>C mutation in a specific area raises the question of the origin of this mutation from a common ancestor. We carried out a genotype-based analysis by way of genotyping a new generated microsatellite marker within the ALDH7A1 gene. Genotype reconstruction of all affected pedigree members indicate that all c.1364T>C mutation carriers harbored the same allele, indicating a common ancestor. The finding of a founder effect in a rare disease is essential for the genetic diagnosis and the genetic counseling of affected PDE pedigrees in Tunisia. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 27 条
[1]   Pyridoxine-dependent and pyridoxine-responsive seizures [J].
Baxter, P .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (06) :416-420
[2]  
Baxter P, 1996, DEV MED CHILD NEUROL, V38, P998
[3]   Consanguinity and endogamy in northern Tunisia and its impact on non-syndromic deafness [J].
Ben Arab, S ;
Masmoudi, S ;
Beltaief, N ;
Hachicha, S ;
Ayadi, H .
GENETIC EPIDEMIOLOGY, 2004, 27 (01) :74-79
[4]   Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures [J].
Bennett, CL ;
Huynh, HM ;
Chance, PF ;
Glass, IA ;
Gospe, SM .
NEUROGENETICS, 2005, 6 (03) :143-149
[5]   Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients [J].
Bennett, Craig L. ;
Chen, Yingzhang ;
Hahn, Sihoun ;
Glass, Ian A. ;
Gospe, Sidney M., Jr. .
EPILEPSIA, 2009, 50 (05) :1167-1175
[6]   Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels [J].
Bok, Levinus A. ;
Struys, Eduard ;
Willemsen, Michel A. A. P. ;
Been, Jasper V. ;
Jakobs, Cornelis .
ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (08) :687-689
[7]   A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31. [J].
Comier-Daire, V ;
Dragoneau, N ;
Burglen, L ;
Munnich, AN ;
Dulac, O .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) :20-20
[8]   Pyridoxine-dependent seizures: Findings from recent studies pose new questions [J].
Gospe, SM .
PEDIATRIC NEUROLOGY, 2002, 26 (03) :181-185
[9]   Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment [J].
Gospe, SM .
CURRENT OPINION IN NEUROLOGY, 2006, 19 (02) :148-153
[10]   PYRIDOXINE-DEPENDENT SEIZURES, CLINICAL AND THERAPEUTIC ASPECTS [J].
HAENGGELI, CA ;
GIRARDIN, E ;
PAUNIER, L .
EUROPEAN JOURNAL OF PEDIATRICS, 1991, 150 (07) :452-455